More on FDMT

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (8.5 Score)

Upcoming Events

- Earnings (11/11/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

4D Molecular Therapeutics Inc. (NQ:FDMT)
Delayed: 12.14 -0.73 (5.67%)
Prev. Close $12.87  
Open$12.84 
52 Wk High$ 
52 Wk Low$ 
Day High$12.84 
Day Low$12.00 
P/E N/A  
EPS$ 
Volume794,535 

Friends, Peers and Foes (?): AURA, NBP, VANI HTGC (more...)

Oct 16, 2026 04:05 PM 4DMT Announces New Employment Inducement Grants
Oct 7, 2026 05:12 PM Form 4 4D Molecular Therapeutic For: Oct 05 Filed by: Kirn David
Oct 5, 2026 06:23 PM Form 144 4D Molecular Therapeutic Filed by: Kirn David
Oct 5, 2026 08:00 AM 4DMT to Host Investor Day on October 21, 2026
Oct 1, 2026 05:05 AM B.Riley Reiterates Buy Rating on 4D Molecular Therapeutics (FDMT)
Sep 29, 2026 04:59 PM This is the top biotech stock pick from B Riley Securities
Sep 29, 2026 05:24 AM 4D Molecular Therapeutics (FDMT) PT Raised to $33 at BofA Securities
Sep 28, 2026 08:05 AM Form 8-K 4D Molecular Therapeutic For: Sep 28
Sep 28, 2026 08:00 AM 4DMT enrolls first patients in Phase 3 DME trial for 4D-150
Sep 28, 2026 08:00 AM 4DMT Advances 4D-150 into Phase 3 for Second Large Market Retina Indication with Initiation of 4SIGHT in DME
View All Articles

Entities mentioned with FDMT

View All Entities